Apart from GAS2L3, we did not observe the strong evidence supporting the significant expression difference of the GAS2, GAS2L1, and GAS2L2 genes between glioma cases and negative controls (Figure 1A,B, Figures S3A and S4A). The gene discussed is GAS2; the disease is glioma.